Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Other hematologic neoplasm 1Lymphoid 1

Conditions

Meningeal Carcinomatosis 2Meningeal Neoplasms 1Lymphoma 1Leukemia 1Glioma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 222Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Interventional × WP 744 × Clear all
NCT00527410 2025-05-30

LMD

Biogen

Phase 1 Terminated
9 enrolled
CNS

Meningeal Carcinomatosis

NCT00526812 2025-05-28

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

Biogen

Phase 1 Completed
54 enrolled
CNS

Glioma

NCT00512460 2016-05-16

RTA 744 Injection in Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
7 enrolled
CNSLymphoidOther hematologic neoplasm

Brain Neoplasms, Leukemia, Lymphoma, Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡